Beijing Centergate Technologies (holding) Co., Ltd. (SHE:000931)

China flag China · Delayed Price · Currency is CNY
4.740
+0.060 (1.28%)
Apr 29, 2026, 3:04 PM CST
3.95%
Market Cap 3.57B
Revenue (ttm) 2.30B
Net Income (ttm) 15.87M
Shares Out 753.13M
EPS (ttm) 0.02
PE Ratio 224.72
Forward PE n/a
Dividend 0.02 (0.43%)
Ex-Dividend Date n/a
Volume 10,392,276
Average Volume 16,954,905
Open 4.960
Previous Close 4.680
Day's Range 4.640 - 4.960
52-Week Range 4.480 - 5.860
Beta 0.56
RSI 35.22
Earnings Date Apr 18, 2026

About SHE:000931

Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical industry in China and internationally. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Bifonazole API, an opioid receptor antagonist; Naloxone Hydrochloride injection to relieve acute ethanol poisoning; Naltrexone Hydrochloride tablets to block the pharmacological effects of exogenous opioids; Hydrocodone acetaminophen tablets for the treatment of moderate to severe pain; Ambroxol Hydrochloride injection for acute and chron... [Read more]

Sector Healthcare
Founded 1999
Employees 2,267
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000931
Full Company Profile

Financial Performance

In 2025, SHE:000931's revenue was 2.44 billion, a decrease of -3.52% compared to the previous year's 2.53 billion. Earnings were 47.89 million, a decrease of -10.65%.

Financial Statements

News

There is no news available yet.